Latest News & Updates
Breaking News
1 day ago
Simantini Singh Deo
Other trending news you may like to read
Essential Pharma Appoints Becki Morison as CEO, Effective 1 July 2026
Becki Morison takes the CEO role at Essential Pharma on 1 July 2026, bringing rare disease and specialty pharma commercial leadership from LEO Pharma and Eli Lilly.
Simantini Singh Deo
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 in Idiopathic Pulmonary Fibrosis
FDA grants GRI Bio Orphan Drug Designation for GRI-0621 in IPF, unlocking seven-year exclusivity and enhanced regulatory engagement.
Simantini Singh Deo
Curium Wins Patent Dispute Against Novartis AAA, Clearing U.S. Path for Lu-177 Dotatate Launch
Delaware court invalidates all Novartis AAA patent claims against Curium, opening U.S. market entry for a second Lu-177 dotatate supplier.
Simantini Singh Deo
Grace Therapeutics Receives FDA CRL for GTx-104 NDA Citing CMC and cGMP Deficiencies at CMO
FDA's CRL for GTx-104 flags CMC leachables gaps and CMO cGMP deficiencies, a resubmission case study for QA and regulatory teams.
Simantini Singh Deo
